Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Research In Motion Ltd (BBRY), Johnson & Johnson (JNJ): What’s The ‘Warren Buffett of Canada’ Up To Now?

Page 1 of 2

Each quarter, hedge funds, such as Prem Watsa’s Fairfax Financial Holdings, file 13F forms with the SEC. These 13F forms disclose many of the positions held in the funds’ equity portfolio during the quarter. Prem Watsa is one of the managers we track at Insider Monkey, and he’s been described as ‘the Warren Buffett of Canada.’ His fund has returned around 100% since 2007.

We will now take a quick look at the five largest equity holdings disclosed in the fund’s first quarter 13F because retail investors can benefit from watching hedge fund sentiment; discover the details of this strategy.

Prem Watsa


The largest equity holding in the Fairfax equity portfolio, according to the 13F, is in mobile telecommunications “comeback kid” Research In Motion Ltd (NASDAQ:BBRY) BlackBerry. According to the 13F, as of March 31, the fund held 51,854,700 shares worth over $749 million in Research In Motion Ltd (NASDAQ:BBRY) BlackBerry, comprising 27.96% of the fund’s total filing.

The Research In Motion Ltd (NASDAQ:BBRY) Blackberry maker is very much a laggard in the mobile telecommunications space, but some analysts believe a successful launch of the BlackBerry Z10 and Q10 smartphones may reverse the company’s fortunes; it reported sales of 1 million Z10s in March 2013, and the company also revealed a profit of $94 million on revenues of $2.7 billion in its first in three quarters of the current fiscal year. This represents a strong contrast from a loss just one year earlier, and has given Watsa reason to celebrate in 2013 thus far.

The best of the rest

The fund’s next largest holding is in pharmaceutical giant Johnson & Johnson (NYSE:JNJ), with 5,941,600 shares worth over $484 million as of March 31, 2013, comprising over 18% of the fund’s total equity portfolio. Johnson & Johnson (NYSE:JNJ) has been long considered a genuinely blue-chip stock, owning many leading brands including Listerine, Splenda and Sudafed; a strong balance sheet and a 50-year history of raising dividends are icing on the proverbial cake. Price action has also been impressive, with company starting the year near $70 to trade at $86.84 as of the time of this writing.

Watsa’s next holding is also unchanged from the prior quarter, a stake of 24,776,519 shares worth over $400 million in paper and lumber company Resolute Forest Products Inc (NYSE:RFP), about 15% of the fund’s total reported equity portfolio. Fairfax now holds nearly 30% of Resolute Forest Products Inc (NYSE:RFP)’s outstanding shares, and the fund’s bullishness may be due to the company’s strong fundamentals; it trades at a mere 0.4 times book, compared with an industry average of 1.4. The company’s forward PE is also near 12.20, indicating clear value here.

Next up is telecommunications company Level 3 Communications, Inc. (NYSE:LVLT), with the fund holding about 12.9 million shares worth approximately $262 million, close to 10% of the fund’s total reported equity portfolio. Watsa’s position may be a vote of confidence in the newly appointed CEO Jeffrey Storey, who has previously turned around another troubled telecom Williams Communications Group, which emerged from Chapter 11 to proceed to a successful acquisition by conglomerate Leucadia National Corp. (NYSE:LUK) in 2003. Another factor may be the possible pending optical networking deal with Infinera Corp. (NASDAQ:INFN) or Ciena Corporation (NASDAQ:CIEN).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!